학술논문

A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH
Document Type
Article
Source
In: Journal of Hepatology. (Journal of Hepatology, April 2022, 76(4):800-811)
Subject
Language
English
ISSN
16000641
01688278